Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Microcavity controlled coupling of excitonic qubits.
Nature communications·2013
Measurement of Z boson production in Pb-Pb collisions at sqrt[s(NN)]=2.76 TeV with the ATLAS detector.
Physical review letters·2013
Measurement of the semileptonic charge asymmetry using B(s)(0) → D(s)μX decays.
Physical review letters·2013
Non-transferrin-bound iron uptake by cardiomyocytes.
Journal of molecular medicine (Berlin, Germany)·2026
Beyond the target: implications of Wnt pathway inhibitors on bone health.
Journal of molecular medicine (Berlin, Germany)·2026
Proteomic analysis reveals divergent inflammatory mechanisms of COVID-associated Guillain-Barré syndrome.
Journal of molecular medicine (Berlin, Germany)·2026
Integrative genetic and functional analysis of autosomal dominant hearing loss in 108 multigenerational families.
Journal of molecular medicine (Berlin, Germany)·2026
Preclinical evaluation of cysteine protease-inhibitor aloxistatin (E64d) for heart failure therapy.
Journal of molecular medicine (Berlin, Germany)·2026
Zinc-binding protein metallothionein 3 protects vascular smooth muscle cells from ferroptosis via blocking lysosomal degradation of GPX4.
Journal of molecular medicine (Berlin, Germany)·2026
Development of a Novel, Eco-Friendly Mechanical Cell Lysis Process Using Hollow Fiber Filter for AAV Manufacturing.
Biotechnology and bioengineering·2026
Programmed repair of disease-causing UGA premature termination codons in mammalian brain.
Nucleic acids research·2026
Case Report: Novel homozygous pathogenic variant of the SPG20 gene causes the Troyer syndrome in China.
Frontiers in genetics·2026
Molecular profiling and functional analyses of umbilical cord mesenchymal stem cell-derived extracellular vesicles for dry eye diseases.
Extracellular vesicles and circulating nucleic acids·2026
Immunotherapy for tuberculosis: current landscape, mechanistic insights, and translational perspectives.
Frontiers in immunology·2026
Real-World Effectiveness and Safety of Tildrakizumab in Patients With Moderate-to-Severe Psoriasis After Failure of Ustekinumab: A Multicenter Retrospective Study.
The Journal of clinical and aesthetic dermatology·2026